2000
DOI: 10.1034/j.1600-0536.2000.043001001.x
|View full text |Cite
|
Sign up to set email alerts
|

Use tests: ROAT (repeated open application test)/PUT (provocative use test): an overview

Abstract: As one step in defining the clinical relevance of exposure to an allergen identified with patch testing, use tests (provocative use test (PUT), and repeated open application test (ROAT)) have been used. In 1 / 2 of the cases of seemingly reliable patch tests, use tests are negative, suggesting that the patient's biologic threshold of response had not been reached with open application dosing. Dramatic differences exist in regional skin reactivity and percutaneous penetration. Negative results of use tests on n… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
44
0
1

Year Published

2002
2002
2019
2019

Publication Types

Select...
5
5

Relationship

5
5

Authors

Journals

citations
Cited by 80 publications
(49 citation statements)
references
References 25 publications
3
44
0
1
Order By: Relevance
“…This should be simplified when more data become available as to appropriate nonirritant patch test concentrations and vehicles together with clinical correlations to provocative use tests/repeat open application tests [Nakada et al, 2000]. An initial serial dilution test is recommended to confirm 'positive' reactions obtained.…”
Section: Resultsmentioning
confidence: 99%
“…This should be simplified when more data become available as to appropriate nonirritant patch test concentrations and vehicles together with clinical correlations to provocative use tests/repeat open application tests [Nakada et al, 2000]. An initial serial dilution test is recommended to confirm 'positive' reactions obtained.…”
Section: Resultsmentioning
confidence: 99%
“…This should be simplifi ed when more data becomes available as to appropriate non-irritant patch test concentrations and vehicles together with clinical correlations to provocative use test/repeat open application tests [24] . Recent expedited schemata for providing fragrance allergens should be of value [25] .…”
Section: Discussionmentioning
confidence: 99%
“…This should be simplified when more data become available as to appropriate nonirritant patch test concentrations and vehicles together with clinical correlations with provocative use test/repeat open application tests [Nakada et al, 2000]. Recent expedited schemata for providing fragrance allergens should be of value [Vey, 2003].…”
Section: Discussionmentioning
confidence: 99%